Page last updated: 2024-09-03

omega-n-methylarginine and Cancer of Ovary

omega-n-methylarginine has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aeberhard, E; Chaudhuri, G; Farias-Eisner, R; Sherman, MP	1

Other Studies

1 other study(ies) available for omega-n-methylarginine and Cancer of Ovary

Article	Year
Nitric oxide is an important mediator for tumoricidal activity in vivo. Proceedings of the National Academy of Sciences of the United States of America, 1994, Sep-27, Volume: 91, Issue:20 Topics: Animals; Antibodies; Arginine; Cell Line; Cell Survival; Cytokines; Female; Humans; Immunity, Innate; Interferon-gamma; Lipopolysaccharides; Mice; Mice, Inbred C3H; Mice, Nude; Mycobacterium bovis; Nitric Oxide; omega-N-Methylarginine; Ovarian Neoplasms; Teratocarcinoma; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1994

Article

Year

Nitric oxide is an important mediator for tumoricidal activity in vivo.

Proceedings of the National Academy of Sciences of the United States of America, 1994, Sep-27, Volume: 91, Issue:20

Topics: Animals; Antibodies; Arginine; Cell Line; Cell Survival; Cytokines; Female; Humans; Immunity, Innate; Interferon-gamma; Lipopolysaccharides; Mice; Mice, Inbred C3H; Mice, Nude; Mycobacterium bovis; Nitric Oxide; omega-N-Methylarginine; Ovarian Neoplasms; Teratocarcinoma; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1994